本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance principles for healthcare This collaborative dialogue explored key challenges and opportunities in unlocking AI's potential, and the optimal governance principles required to develop an agile framework for effectively integrating AI in healthcare Its key principles are rooted in inclusion, equity, and ethics, to ensure patient safety while enabling responsible innovation Participants included academics, technology experts, and pharmaceuticals leaders from across Africa, the US, Europe, Asia, and the Middle East ABU DHABI, UAE, April 24, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, convened senior international government officials at the Health Leaders Roundtable to shape a Declaration on AI governance principles for healthcare. Held on the sidelines of Abu Dhabi Global Health Week (ADGHW), it considered the challenges and opportunities in unlocking the potential of artificial intelligence (AI), and explored key principles in the governance of AI in healthcare. Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable Hosted together with PwC Middle East, findings from the roundtable will inform the development of a collaborative approach that will serve as a reference for governments, health systems, and innovators to ensure that AI's integration into healthcare systems is transparent, responsible, and inclusive. His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, added: "AI is not tomorrow's technology, it is today's reality. While many of us are adapting to its rise, our children will grow up with it as the norm. That's why the decisions we make today, around ethics, equity, and safety, must be made together. Through this declaration, we will establish a globally accessible guideline that extends beyond borders and commercial interests. This document is a call to action for governments, innovators, and healthcare leaders everywhere." The forthcoming Declaration on governance principles for AI in healthcare will outline guiding principles for responsible AI deployment to improve health outcomes and protect patient rights. Designed as a globally accessible resource, the declaration will inspire unified governance and serve as a trusted reference for stakeholders worldwide. In her opening remarks at the Roundtable, Her Excellency Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: "AI has extraordinary potential in healthcare. It is already transforming how we deliver care, how we diagnose, and how we discover. But with great power comes great responsibility. In Abu Dhabi, we are harnessing AI as our engine and policy as our platform, turning data into life-saving insight, and insight into meaningful action. Our vision is to deliver healthcare that is precise, proactive, and personal and to do so in a way that puts people, not technology, at the centre." During the Roundtable, participants emphasised the need for agile legal and regulatory frameworks to enable the safe and ethical application of AI in healthcare, while enabling innovation. With an emphasis on the need for a human-centred approach, discussions explored key themes including standardisation of data, data privacy and trust, skills development and community engagement. Key insights from the Roundtable highlight the need for: Transparent testing frameworks to ensure AI tools meet real-world clinical standards; Collaborative ecosystems that unite regulators, industry, academia, and civil society across geographies; Responsible data access that protects privacy, ensure security, and clarify ownership; Addressing the AI skills gap by scaling education and awareness across healthcare systems and prepare healthcare workforces for a new era. Aligning AI use cases with real-world patient and system challenges, avoiding technology for technology's sake. The Health Leaders Roundtable brought together a distinguished group of local and international voices, including government officials, AI experts, healthcare executives, and multilateral organisations, to explore the shared principles and practices needed to deploy AI responsibly, effectively, and equitably. These themes build on Abu Dhabi's rapidly advancing AI ecosystem, which in the field of health, is taking billions of data points, and turning them into life-changing insights. Supporting the Emirates's approach is the Global AI Healthcare Academy, launched by DoH, which equips healthcare professionals worldwide with theoretical knowledge and hands-on training needed to implement AI technologies effectively, setting a global standard for capacity building. In addition, Malaffi - the region's first Health Information Exchange - provides secure, real-time access to patient data across both public and private healthcare providers. This seamless data integration is crucial for enabling AI tools to be deployed safely, efficiently, and at scale. ADGHW is a major government initiative from DoH, and serves as a platform for innovation and collaboration under the 2025 theme 'Towards Longevity: Redefining Health and Well-being.' By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being. For media inquiries or interview opportunities, please contact: Maroun Farah, Senior Media Relations Manager, Weber ShandwickE: mfarah@webershandwick.com T: +971 55 166 2557
Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance principles for healthcare This collaborative dialogue explored key challenges and opportunities in unlocking AI's potential, and the optimal governance principles required to develop an agile framework for effectively integrating AI in healthcare Its key principles are rooted in inclusion, equity, and ethics, to ensure patient safety while enabling responsible innovation Participants included academics, technology experts, and pharmaceuticals leaders from across Africa, the US, Europe, Asia, and the Middle East ABU DHABI, UAE, April 24, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, convened senior international government officials at the Health Leaders Roundtable to shape a Declaration on AI governance principles for healthcare. Held on the sidelines of Abu Dhabi Global Health Week (ADGHW), it considered the challenges and opportunities in unlocking the potential of artificial intelligence (AI), and explored key principles in the governance of AI in healthcare. Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable Hosted together with PwC Middle East, findings from the roundtable will inform the development of a collaborative approach that will serve as a reference for governments, health systems, and innovators to ensure that AI's integration into healthcare systems is transparent, responsible, and inclusive. His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, added: "AI is not tomorrow's technology, it is today's reality. While many of us are adapting to its rise, our children will grow up with it as the norm. That's why the decisions we make today, around ethics, equity, and safety, must be made together. Through this declaration, we will establish a globally accessible guideline that extends beyond borders and commercial interests. This document is a call to action for governments, innovators, and healthcare leaders everywhere." The forthcoming Declaration on governance principles for AI in healthcare will outline guiding principles for responsible AI deployment to improve health outcomes and protect patient rights. Designed as a globally accessible resource, the declaration will inspire unified governance and serve as a trusted reference for stakeholders worldwide. In her opening remarks at the Roundtable, Her Excellency Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: "AI has extraordinary potential in healthcare. It is already transforming how we deliver care, how we diagnose, and how we discover. But with great power comes great responsibility. In Abu Dhabi, we are harnessing AI as our engine and policy as our platform, turning data into life-saving insight, and insight into meaningful action. Our vision is to deliver healthcare that is precise, proactive, and personal and to do so in a way that puts people, not technology, at the centre." During the Roundtable, participants emphasised the need for agile legal and regulatory frameworks to enable the safe and ethical application of AI in healthcare, while enabling innovation. With an emphasis on the need for a human-centred approach, discussions explored key themes including standardisation of data, data privacy and trust, skills development and community engagement. Key insights from the Roundtable highlight the need for: Transparent testing frameworks to ensure AI tools meet real-world clinical standards; Collaborative ecosystems that unite regulators, industry, academia, and civil society across geographies; Responsible data access that protects privacy, ensure security, and clarify ownership; Addressing the AI skills gap by scaling education and awareness across healthcare systems and prepare healthcare workforces for a new era. Aligning AI use cases with real-world patient and system challenges, avoiding technology for technology's sake. The Health Leaders Roundtable brought together a distinguished group of local and international voices, including government officials, AI experts, healthcare executives, and multilateral organisations, to explore the shared principles and practices needed to deploy AI responsibly, effectively, and equitably. These themes build on Abu Dhabi's rapidly advancing AI ecosystem, which in the field of health, is taking billions of data points, and turning them into life-changing insights. Supporting the Emirates's approach is the Global AI Healthcare Academy, launched by DoH, which equips healthcare professionals worldwide with theoretical knowledge and hands-on training needed to implement AI technologies effectively, setting a global standard for capacity building. In addition, Malaffi - the region's first Health Information Exchange - provides secure, real-time access to patient data across both public and private healthcare providers. This seamless data integration is crucial for enabling AI tools to be deployed safely, efficiently, and at scale. ADGHW is a major government initiative from DoH, and serves as a platform for innovation and collaboration under the 2025 theme 'Towards Longevity: Redefining Health and Well-being.' By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being. For media inquiries or interview opportunities, please contact: Maroun Farah, Senior Media Relations Manager, Weber ShandwickE: mfarah@webershandwick.com T: +971 55 166 2557 Photo - https://mma.prnasia.com/media2/2672529/ADGHW.jpg?p=medium600Logo - https://mma.prnasia.com/media2/2666335/5285303/Abu_Dhabi_Global_Health_Week_Logo.jpg?p=medium600
- Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month - KYOTO, Japan, April 24, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (Head Office: Muko, Kyoto Prefecture; hereinafter referred to as "the Company") is proud to continue its long-term commitment to the sponsorship of May Measurement Month (MMM), an awareness-raising campaign of blood pressure monitoring. As part of this commitment, the Company will donate approximately 4,000 blood pressure monitors to MMM. This year, the donated devices include blood pressure monitors that detect possible atrial fibrillation (AFib) using the new AI-based Intellisense AFib technology, as well as blood pressure monitors featuring integrated ECG technology. Logo: https://kyodonewsprwire.jp/img/202504177579-O1-SWNJGnOc OMRON Healthcare has partnered with MMM since 2017 to promote and help to create awareness of the dangers of raised blood pressure and hypertension and to date has donated approximately 30,000 blood pressure monitors across 100 countries. Now, in its seventh year running, this initiative has been crucial in educating hypertensive patients to measure their blood pressure and to support early detection of AFib to help reduce stroke risk. "Atrial fibrillation is a potentially life-threatening arrhythmia, and people with high blood pressure are at significantly greater risk of developing it. Regular monitoring of blood pressure is a crucial tool in identifying those risks and enables people to manage hypertension more effectively. With the donation of these monitors, we are able to support earlier detection, better treatment and, ultimately, save more lives," said Professor Neil R Poulter, Chief Investigator and Chair of Trustees, of May Measurement Month. According to the World Health Organization (WHO), high blood pressure is responsible for more than 10 million deaths worldwide each year. And alarmingly, approximately 1 in 4 people with AFib are initially asymptomatic.*1 If left untreated, hypertension increases the risk of developing life-threatening cerebrovascular and cardiovascular diseases such as stroke and heart failure. Early detection and proper treatment of hypertension can prevent serious complications. Home blood pressure monitoring is associated with better blood pressure control and therefore enhances prevention. This year's MMM will be held from May 1 to July 31. The event will offer hands-on blood pressure measurements and provide advice on diet and blood pressure management. Additionally, visitors, in some regions, will be able to assess their AFib risk through blood pressure measurements and ECG recordings. Studies have confirmed that the incidence of AFib is about three times higher in hypertensive patients than in those with normal blood pressure*2. By donating blood pressure monitors that can detect the possibility of AFib to MMM, the Company is providing an opportunity to raise awareness of its risks among hypertensive patients. For more information about MMM, please visit: www.maymeasure.org. *1 Gibbs H, et al; Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening. Am J Med. 2021 Jul;134(7):893-901.e11. *2 Senoo K, Yukawa A, Ohkura T, et al. Screening for untreated atrial fibrillation in the elderly population: A community-based study. Pizzi C, ed. PLoS ONE.2022;17(6):e0269506. About OMRON Healthcare Committed to advance health and empower people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision "Going for Zero, Preventive Care for the Health of Society," the Company develops products and services for cardiovascular condition management, remote patient monitoring, respiratory care, and pain therapy devices. These help healthcare professionals and patients to reduce cerebro-cardiovascular events, aggravation of respiratory diseases and restrictions due to chronic pain. With well over 350 million units sold globally*, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals**. Throughout its history, OMRON Healthcare has been striving to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, and provides products and services in over 130 countries***. OMRON Healthcare Group is headquartered in Kyoto, Japan. * Cumulative sales of home-use digital blood pressure monitors worldwide. (as of May 2023) ** 1 Frost & Sullivan Survey, Blood pressure clinician perception tracker surveys. (November 25, 2019, and U.S. News Staff 2020, U.S. News & World Report, accessed June 9, 2020) ** 2 Kantar Health. Survey with cardiologists. (2019) *** Number of the countries where OMRON products and/or services are available (as of March 2023)
SHANGHAI, April 23, 2025 /PRNewswire/ -- April 10, 2025, United Imaging, a global leader in medical imaging and radiotherapy equipment, has signed a memorandum of understanding (MOU) with IHH Healthcare, a world-leading integrated healthcare provider. The agreement, announced during the China International Medical Equipment Fair (CMEF) 2025, marks the beginning of a strategic partnership aimed at improving global access to advanced diagnostic technologies, starting with PET/CT systems. IHH Healthcare operates over 80 hospitals across 10 countries, including Malaysia, Singapore, Turkiye, India, and Greater China, through its portfolio of trusted brands – Acibadem, Mount Elizabeth, Prince Court, Island Hospital, Gleneagles, Fortis, Pantai and Parkway. The collaboration between the two organizations aims to explore potential synergies involving United Imaging's imaging systems and AI solutions, with a view toward supporting diagnostic advancement and improved patient care. Dr. Jusong Xia, President of International Business at United Imaging, said:"We are excited to work with IHH Healthcare to bring advanced medical imaging solutions to their extensive hospital network. Our shared goal is to improve diagnostic capabilities and clinical outcomes through innovative imaging technologies and AI solutions." The initial phase of the collaboration will focus on opportunities to integrate United Imaging's PET/CT systems, providing IHH Healthcare with advanced imaging technologies to support early diagnosis and better treatment planning. United Imaging remains focused on its mission of "Equal Healthcare for All," ensuring that advanced healthcare solutions are accessible to clinicians and patients globally. About United ImagingAt United Imaging, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers across the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All™, we help drive industry progress and bold change. Learn more: https://global.united-imaging.com/en/about-united-imaging
CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million. The transaction is expected to be completed in the second quarter of 2025. Wonder Dragon possesses over 3,000 metric tons of premium Qingzhuan dark tea inventory, comprising 1,670 metric tons of raw materials and 1,350 metric tons of finished products. These premium tea products, known for their medicinal and collectible historical value, provide a solid foundation for BGM Group's research and development efforts. This acquisition strengthens BGM Group's position in the healthcare sector by expanding its health product portfolio and market reach. The company has been at the forefront of integrating AI technology, big data analytics, and biopharmaceutical innovations to modernize traditional industries. Post-acquisition, BGM Group plans to optimize tea production efficiency, enhance product adaptability, and accelerate the development of active ingredients for medicinal applications using its AI-powered decision-making platform. Mr. Xin Chen, CEO of BGM Group, commented: "Wonder Dragon's Qingzhuan dark tea resources, combined with our biotechnology platform, will significantly advance our medicinal tea product development and distribution. By leveraging our technological expertise, we intend to introduce new health-focused tea products like ginseng Qingzhuan dark tea and goji berry Qingzhuan dark tea, further diversifying our 'medicine + tea + health' product ecosystem." About BGM Group Ltd BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. In terms of AI application implementation, the group relies on big data mining and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. Its services cover multiple key scenarios such as sales and marketing, underwriting assessment, claims processing, and customer service. The group is capable of analyzing consumer data, building consumer profiles, accurately predicting insurance needs, and providing highly customized services for consumers. In the field of biopharmaceuticals, the group's biopharmaceutical division mainly produces oxytetracycline API, crude heparin sodium, and licorice preparations, which are widely supplied to the global animal husbandry, pharmaceutical, and drug retail markets. The group deeply integrates AI-assisted decision-making into every link of production and manufacturing, achieving supply chain optimization, process efficiency improvement, and market trend prediction. This provides scientific decision-making basis for the management and offers high-quality products and precise services for consumers. For investor and media inquiries, please contact:info@qiliancorp.com
Silicone, an indispensable material in modern life, stands out in the fields of healthcare, electronics, food, and industry due to its unique properties, including high and low-temperature resistance, non-toxicity, waterproofing, and high elasticity. From everyday food grade utensils to high-precision medical implants, and liquid silicone components that enhance automotive performance, the diverse applications of silicone continue to revolutionize our imagination. This article will delve into the types, characteristics, and wide-ranging applications of silicone, uncovering the mysteries of advanced materials such as platinum-cured silicone, medical-grade silicone, and liquid silicone. It will also compare silicone with similar materials like TPE and latex, providing a comprehensive guide to help you make the most informed product choices. What You Should Know About Silicone Rubber Silicone is not plastic. Its exceptional resistance to extreme temperatures (from -40 to 220°C), non-toxicity, waterproof nature, and high flexibility have made it a star material in medical, electronic, food, and industrial applications. Made from natural silica, silicone is not only safe and non-toxic but also food grade and remarkably stable even in harsh environments. Available in liquid, solid, and foam forms, each type of silicone offers unique benefits in terms of elasticity, strength, and shock absorption. Unlike plastic, which can release toxins and is difficult to decompose, silicone is eco-friendly and durable—making it a safer and more sustainable choice for modern living. In this article, we’ll debunk common myths about silicone and give you a fresh look at this material of the future. Is Silicone Toxic? A Comprehensive Analysis of Silicone Safety Silicone is a versatile polymer material widely used in various aspects of daily life, commonly found in kitchenware, medical devices, and baby products. Food grade and medical-grade silicone are considered safe because they are non-toxic, odorless, heat-resistant, and do not release harmful substances, meeting international safety standards. However, there are also some low-quality products on the market that may contain harmful chemicals, requiring caution during use. Choosing certified brands and carefully reviewing product labels is an effective way to ensure safety. In conclusion, selecting and using silicone products correctly allows you to fully enjoy their convenience and safety. How to distinguish food grade silicone and regular silicone? With growing awareness of food safety, silicone eco-friendly tableware has become a popular alternative to disposable plastic. The key differences between food grade silicone and regular silicone lie in their manufacturing processes, ingredients, and certifications. Food grade silicone undergoes strict testing, uses high-quality imported raw materials, and is certified by international standards such as the FDA and NSF to ensure it is safe for contact with food. Its advantages include high heat resistance, non-toxicity, less odor, and chemical stability, making it suitable for use in tableware, baking tools, and baby products. In contrast, regular silicone is commonly used in industrial products and subject to less stringent quality requirements. Choosing food grade silicone not only protects your health but also aligns with modern demands for environmental sustainability and safety. What is platinum silicone and how safe it is? Platinum silicone is widely used in medical, food, and infant products due to its exceptional safety and stability. This type of silicone is free of metals and uses platinum as a catalyst during the manufacturing process, giving the product a higher temperature resistance range (-40°C to 260°C) and ensuring no harmful substances are released. In addition to its high temperature resistance, platinum silicone also offers excellent breathability, effectively reducing odor retention, making it more suitable for food containers. Compared to regular silicone, platinum silicone has stronger chemical stability, allowing it to better withstand rapid temperature changes and resist corrosion from cleaning agents, ensuring greater durability. As consumers increasingly prioritize health and environmental concerns, more and more manufacturers are choosing platinum silicone to offer safer products to consumers. Medical Grade Silicone: How to define it? Medical-grade silicone is widely used in medical devices and implants due to its excellent biocompatibility and safety. Unlike regular silicone, medical-grade silicone undergoes rigorous testing to ensure it is non-toxic, non-irritating, and hypoallergenic, meeting international certification standards such as FDA and LFGB. These silicone materials offer superior resistance to temperature, bacteria, and radiation, making them suitable for high temperatures, repeated sterilization, and various medical environments. They are used in medical equipment such as respiratory masks, infusion tubes, and implants, ensuring safety for the human body and compliance with medical device regulations. Glory Sun Group focuses on providing medical-grade silicone products that meet international standards, offering high quality and timely supply to meet market demand. How to choose between TPE and Silicone Rubber? Find out their respective characteristics! TPE (Thermoplastic Elastomer) and silicone are two common high-performance materials, each with its own characteristics and advantages. TPE offers excellent elasticity, is cost-effective, and is widely used in applications such as automotive parts, sports equipment, and medical devices. On the other hand, silicone excels in high-temperature resistance and safety, making it commonly found in medical products, baby products, and food grade kitchenware. When selecting a material, the product's specific application needs should be considered. If flexibility and elasticity are a priority, TPE is the ideal choice; if the product needs to withstand high temperatures and offer long-term durability, silicone is recommended. Regardless of the material chosen, it is crucial to find a manufacturer with extensive experience to ensure product quality and production stability. What's the Difference Between Silicone & Latex Silicone and latex are two commonly used high-elasticity materials widely applied in mattresses, medical devices, and everyday products. Silicone, made from silica, is known for its high stability, water resistance, and electrical insulation, making it ideal for use in medical, food grade, automotive, and electronic products. In contrast, latex is derived from natural tree sap and offers excellent elasticity, often used in mattresses, hygiene products, and medical gloves. Silicone is more resistant to high temperatures and chemical exposure, making it suitable for extreme environments, while latex, with its superior flexibility, is ideal for products that require prolonged skin contact. Choosing the right material depends on the specific application needs. In both the medical and food industries, products made from these materials must comply with FDA regulations to ensure safety. High-Temperature Silicone: Characteristics, Applications, and Buying Guide High-temperature silicone plays a crucial role in modern industries due to its exceptional heat resistance, stability, and versatility. It can withstand temperatures up to 300°C or even higher, maintaining its physical and chemical properties. It is widely used in fields such as electronics, automotive, healthcare, food processing, and aerospace. In these industries, high-temperature silicone provides reliable insulation, chemical resistance, and high elasticity, ensuring stable operation of equipment in high-temperature environments. Additionally, the non-toxicity and aging resistance of this material make it especially important in medical devices and food processing. When selecting the appropriate high-temperature silicone products, factors such as temperature range, certification standards, and chemical compatibility should be considered to ensure optimal performance and long-term stability. Applications of Liquid Silicone Rubber Injection Molding in smart clothing Liquid Silicone Rubber (LSR) injection molding technology is increasingly becoming a key material in high-performance sports equipment, offering exceptional comfort, durability, and anti-slip properties. Its advantages include the ability to create precision and complex structures with extremely high elasticity and weather resistance, making it particularly suitable for insoles, knee and elbow pads, and other sports protective gear. Additionally, the integration of liquid silicone rubber with knitted fabrics enhances both the functionality and aesthetics of the products, providing designers with greater room for innovation. These technologies not only improve the protective performance of sports equipment but also ensure long-term reliability, thus enhancing athletic performance and safety. With the advancement of liquid silicone rubber technology, it is expected to play an even greater role in the sports equipment sector, delivering higher-performance products for consumers. Medical Grade Silicone: How to define it? Medical-grade silicone is widely used in medical devices such as respiratory masks, infusion tubes, and implants due to its high biocompatibility, non-toxicity, and hypoallergenic properties, ensuring safety for human use. This type of silicone must pass rigorous testing, including certifications like FDA or LFGB, to confirm its compliance with medical or food-contact standards. Key features of medical-grade silicone include resistance to extreme temperatures, excellent antimicrobial properties, and radiation resistance, making it suitable for repeated disinfection and sterilization processes. Its applications range from medical components to short-term and long-term implants. The Future of Liquid Silicone in Automotive Applications Liquid silicone, as a high-tech material, is increasingly being used in the automotive manufacturing industry to enhance vehicle performance and safety. Its high-temperature resistance and excellent weatherability make it an ideal choice, especially for components such as body seals, lighting systems, electronic component packaging, and automotive glass. The use of liquid silicone not only improves sealing performance but also enhances the waterproofing of headlights and the stability of electronic systems. Furthermore, its lightweight properties help reduce vehicle weight, improve fuel efficiency, and lower carbon emissions, thereby enhancing both vehicle safety and environmental friendliness. In the future, with ongoing technological advancements, liquid silicone will continue to drive innovation and breakthroughs in the automotive industry. Glory Sun Group offers strong technical expertise and quality assurance, and we sincerely welcome your inquiries! In conclusion, silicone's remarkable properties drive diverse applications across healthcare, electronics, food, and industry. Its temperature resistance, non-toxicity, and flexibility make it superior in many uses compared to materials like TPE and latex. For high-quality silicone solutions, feel free to visit the official website of Glory Sun Group. Glory Sun Group Contact Info: 1. TEL: +86-512-5777-7921 2. ADDR.: No.1288-1, Shuixiu Rd., High-tech Industrial Park,Kunshan City, Jiangsu Province, China (PC: 215316)[View Map] 3. Email: yllin@glorysun.com.cn 4. FAX: +86-512-5777-7937
healthcare
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
